Get the Stockscreener App
0.285
1.79%
0.005
Oncology Institute Inc stock is traded at $0.285, with a volume of 20,288.
It is up +1.79% in the last 24 hours and down -10.83% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
See More
Previous Close:
$0.28
Open:
$0.28
24h Volume:
20,288
Relative Volume:
0.17
Market Cap:
$21.14M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-0.3393
EPS:
-0.84
Net Cash Flow:
$-47.97M
1W Performance:
-10.91%
1M Performance:
-10.83%
6M Performance:
-73.36%
1Y Performance:
-85.89%
1-Day Range:
$0.2751
$0.3151
1-Week Range:
$0.2717
$0.3399
52-Week Range:
$0.2717
$2.655
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - GlobeNewswire Inc.
Cancer Care - WellSpan Health
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Indian Oil Corp. shares up 0.76% as Nifty gains - The Economic Times
The Oncology Institute appoints new CFO - Investing.com
Oncology Institute Announces CFO Transition and Strategic Growth Plan - TipRanks
The Oncology Institute Announces CFO Transition - GlobeNewswire
Cardinal Health to acquire Integrated Oncology Network for $1.12B - HealthLeaders Media
Ionis Plans $500M Public Offering - San Diego Business Journal
Itau Unibanco Holding S.A. Buys Shares of 767 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Renaissance Technologies LLC Purchases 69,800 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
ORIX Co. (NYSE:IX) Shares Purchased by American Century Companies Inc. - Defense World
DRW Securities LLC Makes New $2.43 Million Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
Victory Capital Management Inc. Sells 307 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Granite Investment Partners LLC Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion By Reuters - Investing.com
Cardinal Health acquiring Integrated Oncology Network for $1.1B - Fierce healthcare
Cardinal to acquire Integrated Oncology Network for $1.12B in cash - Axios
Cardinal Health to acquire Integrated Oncology Network for $1.1B - Modern Healthcare
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion - PharmaLive
Cardinal Health expands with $1.115B ION acquisition - Investing.com
Cardinal Health to acquire Integrated Oncology Network for $1.115B in cash - TipRanks
Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network - StockTitan
Oncolytics Biotech (NASDAQ:ONCY) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Oncolytics Biotech reports positive results from breast cancer study | 2024-09-19 | Investing News - Stockhouse Publishing
Oscar Health stock soars to 52-week high, hits $23.45 - Investing.com
Oncolytics Phase 2 breast cancer data ‘compelling, says H.C. Wainwright - TipRanks
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech’s Promising Breast Cancer Study - TipRanks
State of New Jersey Common Pension Fund D Sells 26,498 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Share price of Indian Oil Corp. falls as Nifty strengthens - The Economic Times
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI) - BioSpace
BayCare Cancer Institute Breaks Ground on First Proton Therapy Center in Tampa Bay Area - Yahoo Finance
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
3.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):